Cytopia Completes Sale of Alchemia Stake7 July 2006, Melbourne:...

Cytopia Completes Sale of Alchemia Stake

7 July 2006, Melbourne: Cytopia Ltd (ASX:CYT) has completed the sale of its entire
holding of 14.4m shares in Alchemia Ltd (ASX:ACL). The shares were sold to domestic
institutional investors over recent weeks for a total consideration of $15 million.
The cash that has been generated by this sale will support on the ongoing research and
development of the Cytopia pipeline of drug candidates. With a cash holding of
approximately $22 million and the recently announced JAK3 collaboration with Novartis,
the company commences the current financial year in a very strong position.
About Cytopia
Cytopia Ltd is an Australian biotechnology company focused on the discovery and
development of new drugs to treat cancer, immune disorders and cardiovascular diseases.
Cytopia conducts its research and development via subsidiaries based in Melbourne and
New York and specialises in discovering new molecules that can inhibit enzymes known as
kinases, an exciting new class of drugs.